These mice develop well‐characterized, aggressive, tau pathology in forebrain regions concomitant with neurodegeneration and cognitive deficits (Santacruz et al., 2005; pathology illustrated in Supporting Information Figure S1). The gene discussed is MAPT; the disease is Cognitive impairment.